Hironori Ushijima et  al25 showed that the degradation of GATA6 in CRC cell lines inhibits cell proliferation at the progression of the G2/M phase, and cells are more sensitive to chemotherapy by likely regulating JNK signalling. The gene discussed is GATA6; the disease is colorectal carcinoma.